D.E. Shaw & Co
DVAX

D.E. Shaw & Co’s Dynavax Technologies DVAX Stock Holding History

D.E. Shaw & Co’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-632,594
Closed -$9.73M – 4655
2025
Q4 		$9.73M Sell
632,594
-443,753
-41% -$4.89M 0.01% 1780
2025
Q3 		$10.7M Sell
1,076,347
-348,017
-24% -$3.62M 0.01% 1624
2025
Q2 		$14.1M Sell
1,424,364
-1,062,388
-43% -$11.2M 0.01% 1253
2025
Q1 		$32.3M Buy
2,486,752
+568,412
+30% +$7.52M 0.03% 684
2024
Q4 		$24.5M Buy
1,918,340
+486,981
+34% +$5.89M 0.02% 915
2024
Q3 		$15.9M Buy
1,431,359
+590,476
+70% +$6.51M 0.01% 1130
2024
Q2 		$9.44M Buy
840,883
+498,845
+146% +$5.81M 0.01% 1369
2024
Q1 		$4.24M Sell
342,038
-168,219
-33% -$2.19M ﹤0.01% 2009
2023
Q4 		$7.13M Sell
510,257
-309,353
-38% -$4.3M 0.01% 1630
2023
Q3 		$12.1M Buy
819,610
+16,991
+2% +$239K 0.01% 1151
2023
Q2 		$10.4M Buy
802,619
+236,727
+42% +$2.7M 0.01% 1312
2023
Q1 		$5.55M Sell
565,892
-57,585
-9% -$615K 0.01% 1840
2022
Q4 		$6.63M Buy
623,477
+174,351
+39% +$2.03M 0.01% 1824
2022
Q3 		$4.69M Sell
449,126
-194,282
-30% -$2.53M 0.01% 2166
2022
Q2 		$8.1M Sell
643,408
-758,993
-54% -$8.06M 0.01% 1588
2022
Q1 		$15.2M Sell
1,402,401
-679,311
-33% -$8.25M 0.01% 1238
2021
Q4 		$29.3M Buy
2,081,712
+56,165
+3% +$924K 0.02% 840
2021
Q3 		$38.9M Buy
2,025,547
+1,053,737
+108% +$14M 0.04% 645
2021
Q2 		$9.57M Buy
971,810
+554,266
+133% +$5.04M 0.01% 1539
2021
Q1 		$4.1M Buy
417,544
+407,244
+3,954% +$3.36M ﹤0.01% 2002
2020
Q4 		$46K Sell
10,300
-9,546
-48% -$43.2K ﹤0.01% 3849
2020
Q3 		$86K Sell
19,846
-377,318
-95% -$2.69M ﹤0.01% 3720
2020
Q2 		$3.52M Sell
397,164
-1,255,712
-76% -$6.35M ﹤0.01% 1935
2020
Q1 		$5.83M Buy
1,652,876
+580,564
+54% +$2.69M 0.01% 1358
2019
Q4 		$6.13M Sell
1,072,312
-41,235
-4% -$220K 0.01% 1573
2019
Q3 		$3.98M Sell
1,113,547
-650,880
-37% -$2.52M ﹤0.01% 1824
2019
Q2 		$7.04M Sell
1,764,427
-562,285
-24% -$3.26M 0.01% 1347
2019
Q1 		$17M Buy
2,326,712
+32,192
+1% +$315K 0.02% 806
2018
Q4 		$21M Buy
2,294,520
+192,770
+9% +$2.13M 0.03% 694
2018
Q3 		$26.1M Buy
2,101,750
+294,790
+16% +$3.99M 0.03% 655
2018
Q2 		$27.6M Buy
1,806,960
+160,677
+10% +$2.78M 0.04% 572
2018
Q1 		$32.7M Sell
1,646,283
-11,009
-0.7% -$190K 0.04% 479
2017
Q4 		$31M Sell
1,657,292
-597,802
-27% -$12M 0.04% 492
2017
Q3 		$48.5M Buy
2,255,094
+1,515,150
+205% +$24M 0.07% 329
2017
Q2 		$7.14M Buy
739,944
+586,085
+381% +$3.81M 0.01% 1095
2017
Q1 		$915K Buy
+153,859
New +$740K ﹤0.01% 2350
2016
Q3 		– Sell
-34,478
Closed -$503K – 3403
2016
Q2 		$503K Sell
34,478
-375,175
-92% -$6.41M ﹤0.01% 2797
2016
Q1 		$7.88M Buy
409,653
+268,970
+191% +$5.44M 0.01% 993
2015
Q4 		$3.4M Buy
140,683
+117,640
+511% +$2.95M 0.01% 1716
2015
Q3 		$566K Sell
23,043
-78,900
-77% -$2.23M ﹤0.01% 2976
2015
Q2 		$2.39M Sell
101,943
-29,976
-23% -$653K ﹤0.01% 2049
2015
Q1 		$2.96M Sell
131,919
-120,916
-48% -$2.32M ﹤0.01% 1745
2014
Q4 		$4.26M Buy
252,835
+34,464
+16% +$525K 0.01% 1685
2014
Q3 		$3.12M Sell
218,371
-5,683
-3% -$81.9K ﹤0.01% 1890
2014
Q2 		$3.58M Sell
224,054
-4,490
-2% -$67.7K ﹤0.01% 1853
2014
Q1 		$4.11M Sell
228,544
-40,254
-15% -$747K 0.01% 1739
2013
Q4 		$5.27M Buy
268,798
+125,457
+88% +$1.84M 0.01% 1630
2013
Q3 		$1.72M Buy
143,341
+77,399
+117% +$974K ﹤0.01% 2550
2013
Q2 		$725K Buy
+65,942
New +$1.39M ﹤0.01% 2963

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

D.E. Shaw & Co's DVAX Position: Q1 2026 in Review

D.E. Shaw & Co sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 632,594 shares — an estimated $9.73M sold.

D.E. Shaw & Co first reported a position in DVAX in Q2 2013 and held it in 49 quarters. The position peaked at $48.5M in Q3 2017. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • D.E. Shaw & Co reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 632,594 Dynavax Technologies shares in Q1 2026, an estimated $9.73M.
  • D.E. Shaw & Co first reported a position in Dynavax Technologies in Q2 2013 and held it in 49 quarters.
  • D.E. Shaw & Co's Dynavax Technologies position peaked at $48.5M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.